ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2016 ACR/ARHP Annual Meeting

November 11-16, 2016. Washington, DC.

View by Number View by Title View Sessions
View by Date
  • Abstract Number: 2760

    Assessment of Inflammatory Back Pain and Axial Spondyloarthritis in Brazil
  • Abstract Number: 2761

    Sleep Disturbance in Psoriatic Disease: Prevalence and Associated Factors
  • Abstract Number: 2762

    Smoking and Severity of Psoriatic Arthritis
  • Abstract Number: 2763

    New Treatment Option for SAPHO?
  • Abstract Number: 2764

    Unhappiness Is Related to Worse Outcomes for Patients with Ankylosing Spondylitis and Increased Impairment in Daily Life Activities, Results from a Multinational Real-World Sample
  • Abstract Number: 2765

    Practicing What We Preach? Do Psoriatic Arthritis Patients Treated at an Academic Medical Center Meet Caspar Criteria?
  • Abstract Number: 2766

    The Predictive Value of Patient’s and Evaluator’s Global Assessment and Tender and Swollen Joint Count Differences on Treatment Efficacy in Psoriatic Arthritis: Data from a Longitudinal Multicenter Study
  • Abstract Number: 2767

    Minimal Disease Activity Among Psoriatic Arthritis Patients in Canada: Evaluation of Modified Minimal Disease Activity upon Elimination of Each Component
  • Abstract Number: 2768

    Prevalence of Obesity in Patients with Psoriatic Arthritis and Its Impact on the Severity of the Disease
  • Abstract Number: 2769

    Does Gender Make a Difference in “Composite Psoriatic Disease Activity Index (CPDAI)” in Patients with Psoriatic Arthritis?
  • Abstract Number: 2770

    Psoriatic Arthritis Limits Patients’ Abilities to Undertake Activities Crucial for Normal Daily Life and Impacts Happiness, Results from a Multinational Real-World Sample
  • Abstract Number: 2771

    Higher Incident Rates of Comorbidities in Patients with Psoriatic Arthritis (PsA) Compared to Controls
  • Abstract Number: 2772

    Back Pain in Psoriatic Arthritis: Defining Prevalence, Characteristics and Performance of the Different Inflammatory Back Pain Criteria in a Psoriatic Arthritis Cohort
  • Abstract Number: 2773

    Assessment of the Static and Dynamic Balances in Psoriatic Arthritis (PsA) and Their Relations with Clinical, Radiological and Functional Parameters of Feet
  • Abstract Number: 2774

    Framingham Risk Score Discriminates Coronary Atherosclerosis in Psoriatic Arthritis Patient Better Than Other Cardiovascular Scores Do
  • « Previous Page
  • 1
  • …
  • 184
  • 185
  • 186
  • 187
  • 188
  • …
  • 219
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology